<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Institute of Neuroscience</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8EDEB6C6-9747-40A7-B75D-F563FC3D35F1"><gtr:id>8EDEB6C6-9747-40A7-B75D-F563FC3D35F1</gtr:id><gtr:firstName>Zofia</gtr:firstName><gtr:otherNames>Maria</gtr:otherNames><gtr:surname>Chrzanowska-Lightowlers</gtr:surname><gtr:orcidId>0000-0002-0045-3152</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/51EF232E-BFD5-4C54-85F4-ADF4E3C64732"><gtr:id>51EF232E-BFD5-4C54-85F4-ADF4E3C64732</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Neil</gtr:otherNames><gtr:surname>Lightowlers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF011520%2F1"><gtr:id>95ECCAD3-DD49-4A02-AEF8-2498D085F98C</gtr:id><gtr:title>The Mitochondrial End Game : How key proteins control more than just translation termination</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F011520/1</gtr:grantReference><gtr:abstractText>Summary Context of the research All cells in the body need fuel to live. The fuel production is controlled by a sub-compartment in every cell, an organelle called the mitochondrion. This organelle is extremely specialised and is the only part of the cell other than the nucleus that contains the genetic material, DNA. The 'code' in this DNA can be stored temporarily as 'message' molecules. These messages are used to dictate production of 13 proteins that are essential for fuel production. Each message contains signals that recruit the correct machinery required to make the protein and more specifically where to start or stop reading the code in the message. The principal part of this protein synthesis machinery is called a ribosome and is itself composed of ~80 independent proteins that have to be correctly assembled. After assembly is complete the ribosome has to interact with other components/accessory proteins in a particular sequence to ensure that the messages are correctly translated into proteins and accurately assembled to create functional protein complexes that generate fuel for the cell. Research has clearly shown that specific mutations in this mitochondrial DNA or malfunctions in any of the processes that help make and assemble the encoded proteins can lead to mitochondrial disease. These diseases primarily affect the muscles, nerves and brain, are progressive and are presently untreatable. Aims, objectives, potential applications, benefits The machinery needed to convert the messages in the mitochondrial DNA into functional proteins is considerably more complex than described above. From the little that is currently known about the human mitochondrial machinery, we know it is different to the machinery in the rest of the cell and different again to the bacterial and yeast systems. Even after decades of work on the latter 3 systems, where the key players in this translation process are known, there remains a great deal to be learned about new interactors and modes of regulation. Contrastingly, in human mitochondria, many of the key players have yet to be identified and this needs to be done in order to understand the basic mechanisms and the subtleties of regulation. We have now identified 3 proteins that are critical in the final stage of protein synthesis. Two are release factors that recognise the STOP signals in these 'messages'. The third is a ribosome recycling factor believed to assist in dis-assembling the ribosome ready for a new round of protein synthesis. As part of this work we will further characterise these, identify their structures and so clarify the mechanism by which they operate. A further aim of this proposal is to use technology already established in our group to trap, isolate and identify the cohort of proteins responsible for this critical function of mitochondrial protein synthesis. Using as 'bait' proteins that we have already shown are involved in synthesis and assembly, we can isolate currently unidentified proteins that interact very strongly. These are likely to be involved in or modulate, translation or assembly. We will then identify how these components contribute to organellar function, and how malfunction might cause disease. By generating a more complete picture of the key players in these processes governing protein synthesis and assembly we will gain a better understanding of how these proteins function. These are all proteins that are encoded by the nuclear DNA but are part of the mitochondrion. It is important to know how each of these newly identified proteins works normally to allow us to recognise how changes in them may cause disease. There is currently no therapy available for diseases caused by defects in the mitochondrially encoded proteins so this research is important as it will identify nuclear encoded proteins that crucial for healthy mitochondria that could be targets for future gene therapies and so help develop strategies to avoid mitochondrial disease.</gtr:abstractText><gtr:technicalSummary>Technical summary: Mitochondria are essential eukaryotic organelles. They perform many critical functions for the cell, one of which is to house the five multi-subunit complexes that couple ATP synthesis to cellular respiration, OXPHOS. Vital to this process is the synthesis of thirteen polypeptides in the mitochondrial matrix that are encoded by the organelles genome, mtDNA. Defects in the expression of mtDNA cause a wide variety of human disease and have been implicated in the ageing process. Given the importance of mitochondrial gene expression for cell viability, our relative lack of in depth knowledge of this process is concerning and it is important to address this. In our proposal, we intend to identify and characterise key players in one major aspect of mitochondrial gene expression - post-transcriptional mechanisms such as mRNA metabolism, translation termination, membrane insertion facilitators and OXPHOS complex integrators. In particular, we intend to test our hypothesis that the spatio-temporal coordination of mitochondrial translation and membrane insertion is exquisitely important for correct OXPHOS complex assembly. We intend to build on our recent work on translation termination and our substantial preliminary data to identify critical factors and characterise the molecular mechanisms underlying post-transcriptional gene expression. We will determine the exact mechanisms of translation termination using in vivo and in vitro assays. We will utilise our FLAG tag system to identify proteins associated with mitoribosomes and transcript poly(A) tails. Finally, we will assess the roles of several additional proteins whose yeast orthologues have been shown to facilitate membrane insertion and assembly of nascent mitochondrial polypeptides. These studies will greatly advance our current knowledge of the players and mechanism that underlie mitochondrial gene expression in man.</gtr:technicalSummary><gtr:fund><gtr:end>2011-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>622833</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have generated a significant number of publications arising from the work &amp;amp; personnel funded by this project. The highlights relative to the original aims are:



Aim i &amp;quot;determine the role of mRNA polyadenylation in mitochondrial gene expression.&amp;quot; We showed that this modification stimulates protein synthesis. This is a surprise as the mechanism that evokes this in the eukaryotic cytosol requires a cap-binding complex that is absent in mitochondria interacting via a poly(A) binding protein, which again has not been identified in mitochondria. Published with PDRA as 1st author Wydro et al (2010). We established a collaboration with a group who had identified patients with a mutation in the mitochondrial poly(A) polymerase. Both PIs were co-authors (ZCL expts, RNL intellectual contribution/last author) Work on this project is ongoing.



Aim ii &amp;quot;elucidate the process of translation termination..&amp;quot; For 30 years human mitochondria were believed to have altered their codon usage of AGA / AGG from arginine to stop codons. Our work identified this is not the case but that human mitochondrial ribosomes frameshift. This is unusual for many reasons but crucially as this happens after translation of the orf is complete. A -1 shift positions a standard UAG in the A-site facilitating release activity from mtRF1a, a protein previously characterised by this lab. This was published in Science.



Aim iii &amp;quot;identify &amp;amp; characterize new factors central to post-transcriptional gene expression&amp;quot; We identified that a newly classified member of the mito-release factor family has been incorporated into the mitoribosome. This is exciting &amp;amp; unusual as the protein ICT1 (now accepted as MRPL58) has retained the ability to hydrolyse the peptide from the P-site tRNA, generating a potentially fatal combination. This ICT1 activity must be tightly regulated to prevent premature release of all elongating polypeptides. We believe this represents the 1st example of quality control in human mito-protein synthesis and are continuing to work on this to identify the molecular mechanism. Published in EMBO J.



Aim iv &amp;quot;assess role several mitoribosome associated factors in translation related processes&amp;quot; We have identified a mitoribosome assembly factor that acts as a chaperone for the mt-rRNA and its incorporation into the small ribosomal subunit. Unfortunately while our manuscript was in preparation EraL1 was published as a mitochondrial protein by another group. Although disappointing because it reduced the impact of our work, our data was more extensive and demonstrated the first mt-rRNA chaperone, and this aspect was still novel and allowed publication of our work in BJ. PDRAs Wydro &amp;amp; Rozanska as co-authors Our work showed clear roles in mito-translation, at a conference it became apparent another group had complementing patient derived data. We collaborated &amp;amp; published together combining basic &amp;amp; patient data in Am J Hum Genet.</gtr:description><gtr:exploitationPathways>Has been useful to scientists working in the field of mitochondrial biology.</gtr:exploitationPathways><gtr:id>0D741BF5-417A-487E-818D-3537364B0602</gtr:id><gtr:outcomeId>r-355770532.3731252779e8826</gtr:outcomeId><gtr:sectors><gtr:sector>Other</gtr:sector></gtr:sectors><gtr:url>http://www.newcastle-mitochondria.com/portfolio/professor-zofia-chrzanowska-lightowlers/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D452047B-DA4B-496F-826C-25B2386C9E52</gtr:id><gtr:title>Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28628804526efe2b2fb3f23a2324943e"><gtr:id>28628804526efe2b2fb3f23a2324943e</gtr:id><gtr:otherNames>Kemp JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_5435ad45ad4f46871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16C166A1-D58F-4C8E-8D24-4F115D25B3C9</gtr:id><gtr:title>C7orf30 specifically associates with the large subunit of the mitochondrial ribosome and is involved in translation.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f96bb7d347fda66266352dbf74ade2b3"><gtr:id>f96bb7d347fda66266352dbf74ade2b3</gtr:id><gtr:otherNames>Wanschers BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5675d66876361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>286592D1-8543-4217-88A5-495C651B879F</gtr:id><gtr:title>The human RNA-binding protein RBFA promotes the maturation of the mitochondrial ribosome.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d02086bf9b4ae373f5475e3bb60881ef"><gtr:id>d02086bf9b4ae373f5475e3bb60881ef</gtr:id><gtr:otherNames>Rozanska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>5a35f4fbeeb6f5.48946783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A1BA0BD-D7B2-400D-ABD3-505094F7E839</gtr:id><gtr:title>Termination of protein synthesis in mammalian mitochondria.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35c865141176301c795a9190e81a9683"><gtr:id>35c865141176301c795a9190e81a9683</gtr:id><gtr:otherNames>Chrzanowska-Lightowlers ZM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_53cbff0bff01eb5a8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A8C4ECA-4947-4106-94B4-C818ACBFBC2F</gtr:id><gtr:title>A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c771a26835084178829fa23e6734444"><gtr:id>3c771a26835084178829fa23e6734444</gtr:id><gtr:otherNames>Richter R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_5435ad45ad4a8dd2b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1936A1B-E055-4661-A27A-FC702708219B</gtr:id><gtr:title>Defective mitochondrial mRNA maturation is associated with spastic ataxia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47ac5cb2e465b2417041045a4b8c75a7"><gtr:id>47ac5cb2e465b2417041045a4b8c75a7</gtr:id><gtr:otherNames>Crosby AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_5435ad45ad4b42944</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D4E4B8A-8EFB-45A6-99F4-3A62E0F9E776</gtr:id><gtr:title>Terminating human mitochondrial protein synthesis: a shift in our thinking.</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee62e53aa807f0b784d06e9a75e65323"><gtr:id>ee62e53aa807f0b784d06e9a75e65323</gtr:id><gtr:otherNames>Lightowlers RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn><gtr:outcomeId>pm_53cbfc0bfc0f27c1c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5046C9BD-96D4-4D2F-8AF7-D00C6059EDCA</gtr:id><gtr:title>Translation termination in human mitochondrial ribosomes.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c771a26835084178829fa23e6734444"><gtr:id>3c771a26835084178829fa23e6734444</gtr:id><gtr:otherNames>Richter R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_5435ad55ad50b1bd8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B6391A0-71D9-49B5-BCF3-77F7EB673BB1</gtr:id><gtr:title>Targeting of the cytosolic poly(A) binding protein PABPC1 to mitochondria causes mitochondrial translation inhibition.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e3716bd752212b9cf2c3580d9dd72a5"><gtr:id>1e3716bd752212b9cf2c3580d9dd72a5</gtr:id><gtr:otherNames>Wydro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56758d24e0d67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DE578FB-505C-44AC-AF3F-B8B0739A6FEB</gtr:id><gtr:title>NOA1 is an essential GTPase required for mitochondrial protein synthesis.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e437e29a9d3a0fd775d3e33bc23a69db"><gtr:id>e437e29a9d3a0fd775d3e33bc23a69db</gtr:id><gtr:otherNames>Kolanczyk M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>56758e6a295cf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED7B3581-1F3B-4ABD-B4F3-3205DD028E68</gtr:id><gtr:title>Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19fd4504ba711d599de3fabaf0f5338a"><gtr:id>19fd4504ba711d599de3fabaf0f5338a</gtr:id><gtr:otherNames>Horvath R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_5435ad45ad4deaa27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA2DC6BB-D2B2-4270-B57A-957DB58DDA8E</gtr:id><gtr:title>Mutations in mitochondrial ribosomal protein MRPL12 leads to growth retardation, neurological deterioration and mitochondrial translation deficiency.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cbbbd90559a462b5da509e5b49a83a5"><gtr:id>2cbbbd90559a462b5da509e5b49a83a5</gtr:id><gtr:otherNames>Serre V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5675d83c00da1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09B1B165-36C1-427D-A111-6B579D254D44</gtr:id><gtr:title>Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30dd85d88206d6adfe984afbb86b7577"><gtr:id>30dd85d88206d6adfe984afbb86b7577</gtr:id><gtr:otherNames>Antonicka H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_5435ad45ad4e95292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DB03512-0545-49A0-A08D-00444D437D39</gtr:id><gtr:title>GRSF1 regulates RNA processing in mitochondrial RNA granules.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58177e148276fe2b07667848d4b4c47a"><gtr:id>58177e148276fe2b07667848d4b4c47a</gtr:id><gtr:otherNames>Jourdain AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>5675d8204fb1a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8956D2EB-C26E-4C03-B185-039769A286DB</gtr:id><gtr:title>REXO2 is an oligoribonuclease active in human mitochondria.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5638353c3db22e4dd64b9cb644d45641"><gtr:id>5638353c3db22e4dd64b9cb644d45641</gtr:id><gtr:otherNames>Bruni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675d867293ca</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBCB853D-E51C-469F-96B4-3F3F63B6A37C</gtr:id><gtr:title>PPR (pentatricopeptide repeat) proteins in mammals: important aids to mitochondrial gene expression.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee62e53aa807f0b784d06e9a75e65323"><gtr:id>ee62e53aa807f0b784d06e9a75e65323</gtr:id><gtr:otherNames>Lightowlers RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_53cbf8bbf8b5c83c0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC84259-0EC5-447A-98CE-D04B72222D78</gtr:id><gtr:title>The mystery of mitochondrial RNases.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5638353c3db22e4dd64b9cb644d45641"><gtr:id>5638353c3db22e4dd64b9cb644d45641</gtr:id><gtr:otherNames>Bruni F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>5675d7564ed90</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E64889D-DAFF-44AB-939F-87D09B6D8CDF</gtr:id><gtr:title>Hungry codons promote frameshifting in human mitochondrial ribosomes.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6da22d89bfe90f8cd634036402643da"><gtr:id>b6da22d89bfe90f8cd634036402643da</gtr:id><gtr:otherNames>Temperley R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_5435ad45ad4d44fb1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B24AD089-BC9E-44E4-B831-B64D51EA50EF</gtr:id><gtr:title>Human mitochondrial mRNAs--like members of all families, similar but different.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c2e7614039dc7fa31a1c215a17620d9"><gtr:id>2c2e7614039dc7fa31a1c215a17620d9</gtr:id><gtr:otherNames>Temperley RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_5435ad45ad4c91b47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8ED4122-9A97-4F18-810A-C3D885EB8024</gtr:id><gtr:title>The human mitochondrial ribosome recycling factor is essential for cell viability.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32c739ac12bf8fb6b582f9ac7f6af3f3"><gtr:id>32c739ac12bf8fb6b582f9ac7f6af3f3</gtr:id><gtr:otherNames>Rorbach J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_5435ad45ad4ff123d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77EEF4F0-4F6E-4692-9E00-B4D1C07FF487</gtr:id><gtr:title>Human ERAL1 is a mitochondrial RNA chaperone involved in the assembly of the 28S small mitochondrial ribosomal subunit.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1515ca08ae8b8019d88fa67bfca0b8b"><gtr:id>d1515ca08ae8b8019d88fa67bfca0b8b</gtr:id><gtr:otherNames>Dennerlein S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_5435ad45ad4be4b3d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0507C6AD-1759-4B90-B7F4-987CEC60BB51</gtr:id><gtr:title>Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebf6c74a5fa55520553ddc40b731c151"><gtr:id>ebf6c74a5fa55520553ddc40b731c151</gtr:id><gtr:otherNames>Hornig-Do HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>5675d9942a123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8404B36-2AC9-4F27-8A1D-3D7FE4279ABA</gtr:id><gtr:title>Fine mapping of interactions between eEF1alpha protein and 3'UTR of metallothionein-1 mRNA.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b11a74e76515554a7ac62e7549a23d02"><gtr:id>b11a74e76515554a7ac62e7549a23d02</gtr:id><gtr:otherNames>Fan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>56758c0a4a6cc</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F011520/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>